date,title,source
Oct-29-18,Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966,GlobeNewswire
Nov-05-18,Precision Therapeutics CEO Talks with Uptick Newswires Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and Whats on the Horizon,GlobeNewswire
Nov-07-18,Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation,GlobeNewswire
Nov-08-18,"Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018",GlobeNewswire
Nov-14-18,Precision Therapeutics Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-14-18,"Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer",GlobeNewswire
Jan-17-19,Precision Therapeutics Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Center,GlobeNewswire
Jan-18-19,"Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz",GlobeNewswire
Jan-22-19,"Precision Therapeutics Has Groundbreaking Approach to Personalized Cancer Treatment, Reports CEOCFO Magazine",ACCESSWIRE
Jan-25-19,Precision Therapeutics Skyline Medical Division Widens Global Reach Through New Taiwanese Distribution Agreement with Winner Scientific,GlobeNewswire
Feb-05-19,"Precision Therapeutics TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Models",GlobeNewswire
Feb-07-19,Precision Therapeutics Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria,GlobeNewswire
Feb-19-19,Precision Therapeutics Inc. is Excited to Announce a Special Meeting of Stockholders and Commencement of Registered Exchange Offer,GlobeNewswire
Feb-26-19,Precision Therapeutics Inc. Announces Proposed Public Offering of Securities,GlobeNewswire
Feb-27-19,Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.26 Million of Units,GlobeNewswire
Mar-01-19,Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc.,GlobeNewswire
Mar-05-19,Precision Therapeutics Skyline Medical Division Captures Market Share in Saudi Arabia Via New Orders While Disposable Sales Show Significant Year-Over-Year Increase,GlobeNewswire
Mar-14-19,Precision Therapeutics Extends Exchange Offer for Helomics Notes and Warrants,GlobeNewswire
Mar-21-19,Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients,PR Newswire
Mar-25-19,"Precision Therapeutics to Report Fiscal Year 2018 Financial Results and Provide Company Update on Monday, April 1, 2019",GlobeNewswire
Mar-25-19,Precision Therapeutics Announces Results of Special Meeting of Stockholders,GlobeNewswire
Mar-26-19,Precision Therapeutics Inc. Announces Proposed Public Offering of Securities,GlobeNewswire
